Join the Revolution of On-Dose Authentication

Exploring the Critical Challenges, Existing Solutions, and Advanced Technologies in the Fight Against Counterfeit Drugs

13

November

  • 3pm London 10am New York
  • Free

Why attend?

The pharmaceutical industry is grappling with a critical challenge: the proliferation of counterfeit drugs. This issue is driven by several factors, including the high cost of proprietary medications, the increasing use of the internet for drug sales, the minimal legal risks associated with counterfeiting, and the relative ease of producing counterfeits. This global crisis generates a staggering $200 to $432 billion annually for counterfeiters and is responsible for over 1,000,000 preventable deaths each year. In response, pharmaceutical companies have implemented measures like tracking systems and tamper-evident packaging, but these methods have significant limitations.

Our expert speakers—Zachary Eisenberg, Vice President; Nikolay Barashkov, Director of R&D and Technical Services; Stephen Keteltas, Senior Manufacturing Chemist; and Alyssa Tabucao, Product Manager of SECURtracers—will delve into the current landscape of counterfeit pharmaceuticals. They will review existing solutions, highlight the need for innovative approaches such as on-dose authentication, and introduce their novel SECURtracers technology.

While the fight against counterfeit drugs is complex and ongoing, innovations like on-dose authentication offer a promising advancement in safeguarding patients and maintaining the integrity of the pharmaceutical supply chain. By adopting these solutions, manufacturers can significantly reduce liabilities, prevent revenue loss, protect their brands, and most importantly, save lives. Stay ahead of the curve and safeguard the future of healthcare—register today!

 

Learning Objectives:

  • Understand the scope and impact of counterfeit pharmaceuticals
  • Evaluate current anti-counterfeiting measures and their limitations
  • Explore innovative solution, SECURtracers, for on-dose authentication
  • Learn about how SECURtracers technology is used to code solid oral dosage form drugs

Speakers

Select a speaker to learn more

Back
Alyssa Tabucao
Product Manager

Alyssa Tabucao earned her B.S. degree in Medicinal & Synthetic Chemistry from the University of San Francisco. She plays a pivotal role in overseeing the marketing, development, and improvement of SECURtracers within the company, ensuring compliance with EXCiPACT GMP and ISO 9001 regulations.

Next speaker
Back
Nikolay Barashkov
Director of R&D and Technical Services

Dr. Nikolay Barashkov is an internationally recognized scientist with 40 years of experience in polymer chemistry, photochemistry and photophysics, as well as nanotechnology.

He earned his Master degree in polymer and organic chemistry and technology from Institute of Fine Chemical Technology, his PhD in polymer chemistry and Doctor of Sciences from Karpov Institute of Physical Chemistry.

He has co-written eight books (3 published in English, and 5 in Russian), 150+ peer-reviewed papers, and holds 30 Russian, European and US Patents. Prior to joining Micro-Tracers, Inc., Dr. Barashkov accrued extensive experience in academia and industry working on the synthesis and study of new polymer-based materials (pigments, inks, coating, active media for light-emitting diodes, lasers, plastic scintillators).

As the Director of R&D and Technical Services at Micro-Tracers, Inc. he is responsible for R&D and QC for all Micro-Tracers, including newly developed SECURtracers.

Next speaker
Back
Stephen Keteltas
Senior Manufacturing Chemist

Stephen Keteltas earned his B.S. degree in Chemistry and Biochemistry from Florida State University, followed by an M.S. degree in Chemistry from the University of California, San Diego. With a background in Pharmaceutical Chemistry and Organic Synthesis, he has accrued a decade of experience in the Manufacturing Department, with a focus on the development of SECURtracers. Stephen contributes to a range of R&D projects within the department.

Next speaker
Back
Zachary Eisenberg
Vice President

Zachary Eisenberg has worked for Micro-Tracers, Inc. since 2011. He is the son of current President David Eisenberg and grandson of Founder Sylvan Eisenberg.

After graduating with his MBA from the University of Michigan Ross School of Business in 2014, he has acted as Vice President of both Micro-Tracers, Inc. and Anresco Laboratories.

Next speaker

Enquiry